| 000 | 01382 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517094538.0 | ||
| 264 | 0 | _c20171120 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1095-6859 | ||
| 024 | 7 |
_a10.1016/j.ygyno.2016.05.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFuh, Katherine | |
| 245 | 0 | 0 |
_aSummary of the 2016 American Association for Cancer Research (AACR) Annual Meeting. _h[electronic resource] |
| 260 |
_bGynecologic oncology _c07 2016 |
||
| 300 |
_a9-12 p. _bdigital |
||
| 500 | _aPublication Type: Congress | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiomedical Research |
| 650 | 0 | 4 | _aCRISPR-Cas Systems |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aEpigenesis, Genetic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Editing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplasms _xgenetics |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 |
_aUterine Cervical Neoplasms _xepidemiology |
| 700 | 1 | _aVlad, Anda M | |
| 700 | 1 | _aLanden, Charles N | |
| 773 | 0 |
_tGynecologic oncology _gvol. 142 _gno. 1 _gp. 9-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ygyno.2016.05.013 _zAvailable from publisher's website |
| 999 |
_c26021798 _d26021798 |
||